Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 8894

Edit search filters
  1. A Study of ONO-7475 in Patients With Acute Leukemias

    Jacksonville, FL

  2. Test-retest Comparison of the Lower Quarter Y-Balance Test

    Rochester, MN

  3. Imaging of Systemic Light Chain Cardiac Amyloidosis and Whole-Body Amyloidosis

    Jacksonville, FL

  4. Eosinophilic Esophagitis Pilot Trial of Baked Milk Tolerance

    Rochester, MN

  5. Quanta Home Run Trial

    Rochester, MN

  6. Marani Health M Care Study

    Rochester, MN

  7. Function of Artificial Intelligence-enabled Electrocardiogram in Early Detection of Patients With Aortic Stenosis

    Rochester, MN

  8. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors

    Jacksonville, FL, Rochester, MN

  9. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7303509 in Participants With Systemic Sclerosis

    Rochester, MN

  10. A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer